Advertisement
Advertisement

JAGX

JAGX logo

Jaguar Health, Inc.

0.66
USD
Sponsored
+0.07
+11.43%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

0.67

+0.01
+1.36%

JAGX Earnings Reports

Positive Surprise Ratio

JAGX beat 13 of 30 last estimates.

43%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$4.30M
/
-$4.34
Implied change from Q3 25 (Revenue/ EPS)
+39.32%
/
-30.89%
Implied change from Q4 24 (Revenue/ EPS)
+23.96%
/
+1176.47%

Jaguar Health, Inc. earnings per share and revenue

On Nov 18, 2025, JAGX reported earnings of -6.28 USD per share (EPS) for Q3 25, missing the estimate of -5.18 USD, resulting in a -21.20% surprise. Revenue reached 3.08 million, compared to an expected 3.80 million, with a -18.97% difference. The market reacted with a -8.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -4.34 USD, with revenue projected to reach 4.30 million USD, implying an decrease of -30.89% EPS, and increase of 39.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Jaguar Health, Inc. reported EPS of -$6.28, missing estimates by -21.2%, and revenue of $3.08M, -18.97% below expectations.
The stock price moved down -8.03%, changed from $1.80 before the earnings release to $1.66 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 3 analysts, Jaguar Health, Inc. is expected to report EPS of -$4.34 and revenue of $4.30M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement